| Code | 2612C | ||||||||||
| MA number | 21/0009/17-S | ||||||||||
| Product Form: | tbl flm 50x600 mg (blis.PVC/PE/PVDC/PE/PVC/Al) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| Therapeutic Class: | 21 - ANTIEPILEPTICA, ANTICONVULSIVA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 19.01.2017 |
| Pediatric indication: | Yes |
| Pediatric posology: | Yes |
| Pediatric warnings: | Yes |
| PIL: |
PIL_Gabapentin Teva Slovakia 600 mg_03.2023.pdf
|
| SPC: |
SPC_Gabapentin Teva Slovakia 600mg_03.2023.pdf
|
| Safety feature | Yes |
| Data update: | 12.04.2021 |
